Rethinking tetracycline in the Anthropocene: From miracle drugs to emerging environmental contaminants

Tetracyclines (TCs) have been deployed for over seven decades in clinical and veterinary medicine due to their ability to inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit. Their intensive use, particularly in confined animal feeding operations and aquaculture, has resulted in persistent environmental inputs, as 40-90 % of administered TC is excreted unchanged or as bioactive metabolites. These compounds exhibit strong chelation with divalent cations and high affinity for soil organic matter, facilitating their long-term retention in soils, sediments, and manure-amended agricultural systems. Traditional remediation technologies-advanced oxidation, photocatalysis, membrane separation, and activated carbon adsorption achieve variable TC removal but are constrained by high energy consumption, catalyst deactivation, or secondary pollutant formation. Consequently, research has shifted toward mechanistically informed biocatalytic and hybrid bioremediation frameworks. Bacterial taxa such as Arthrobacter, Klebsiella spp., and Bacillus spp. have demonstrated TC degradation through enzymatic pathways involving oxidative deamination, CC ring cleavage, lactone hydrolysis, and transformation into less bioactive intermediates (e.g., anhydrotetracycline, epitetracycline). Algae and higher plants contribute via biosorption, intracellular sequestration, and conjugation to secondary metabolites. Recent advances integrate biochar-supported microbial biofilms, nanotechnology, metal-organic framework (MOF), that exploit electron transfer pathways to accelerate TC transformation. These hybrid technologies couple physicochemical and biological mechanisms to enhance removal kinetics, reduce toxic by-product generation, and strengthen the resilience of treatment systems. Collectively, such mechanistically grounded approaches offer promising strategies for mitigating TC contamination in heterogeneous natural and engineered environments.

Authors

Institutions

Publication Details

Journal
The Science of The Total Environment
Published
2025-12-23
DOI
https://doi.org/10.1016/j.scitotenv.2025.181265
Primary Topic
Pharmaceutical and Antibiotic Environmental Impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rethinking tetracycline in the Anthropocene: From miracle drugs to emerging environmental contaminants

Chandra Kant Singh, Saurav Singh Rawat, Nikhil S Kumar, Nitin V et al.
The Science of The Total Environment
Pharmaceutical and Antibiotic Environmental Impacts
article

Rethinking tetracycline in the Anthropocene: From miracle drugs to emerging environmental contaminants

Chandra Kant Singh, Saurav Singh Rawat, Nikhil S Kumar, Nitin V, Kushneet Kaur Sodhi
article en

Abstract

Tetracyclines (TCs) have been deployed for over seven decades in clinical and veterinary medicine due to their ability to inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit. Their intensive use, particularly in confined animal feeding operations and aquaculture, has resulted in persistent environmental inputs, as 40-90 % of administered TC is excreted unchanged or as bioactive metabolites. These compounds exhibit strong chelation with divalent cations and high affinity for soil organic matter, facilitating their long-term retention in soils, sediments, and manure-amended agricultural systems. Traditional remediation technologies-advanced oxidation, photocatalysis, membrane separation, and activated carbon adsorption achieve variable TC removal but are constrained by high energy consumption, catalyst deactivation, or secondary pollutant formation. Consequently, research has shifted toward mechanistically informed biocatalytic and hybrid bioremediation frameworks. Bacterial taxa such as Arthrobacter, Klebsiella spp., and Bacillus spp. have demonstrated TC degradation through enzymatic pathways involving oxidative deamination, CC ring cleavage, lactone hydrolysis, and transformation into less bioactive intermediates (e.g., anhydrotetracycline, epitetracycline). Algae and higher plants contribute via biosorption, intracellular sequestration, and conjugation to secondary metabolites. Recent advances integrate biochar-supported microbial biofilms, nanotechnology, metal-organic framework (MOF), that exploit electron transfer pathways to accelerate TC transformation. These hybrid technologies couple physicochemical and biological mechanisms to enhance removal kinetics, reduce toxic by-product generation, and strengthen the resilience of treatment systems. Collectively, such mechanistically grounded approaches offer promising strategies for mitigating TC contamination in heterogeneous natural and engineered environments.

The Science of The Total EnvironmentVol. 1012
University of Delhi (IN), Guru Teg Bahadur Hospital (IN)
Openalex Percentile: Top 50%
Pharmaceutical and Antibiotic Environmental Impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.